These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38404014)

  • 1. Patients Perceptions of Artificial Intelligence in a Deep Learning-Assisted Diabetic Retinopathy Screening Event: A Real-World Assessment.
    Malerbi FK; Mezzomo Ventura B; Fischer M; Penha FM
    J Diabetes Sci Technol; 2024 May; 18(3):750-751. PubMed ID: 38404014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study.
    Bellemo V; Lim ZW; Lim G; Nguyen QD; Xie Y; Yip MYT; Hamzah H; Ho J; Lee XQ; Hsu W; Lee ML; Musonda L; Chandran M; Chipalo-Mutati G; Muma M; Tan GSW; Sivaprasad S; Menon G; Wong TY; Ting DSW
    Lancet Digit Health; 2019 May; 1(1):e35-e44. PubMed ID: 33323239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world artificial intelligence-based opportunistic screening for diabetic retinopathy in endocrinology and indigenous healthcare settings in Australia.
    Scheetz J; Koca D; McGuinness M; Holloway E; Tan Z; Zhu Z; O'Day R; Sandhu S; MacIsaac RJ; Gilfillan C; Turner A; Keel S; He M
    Sci Rep; 2021 Aug; 11(1):15808. PubMed ID: 34349130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients.
    Heydon P; Egan C; Bolter L; Chambers R; Anderson J; Aldington S; Stratton IM; Scanlon PH; Webster L; Mann S; du Chemin A; Owen CG; Tufail A; Rudnicka AR
    Br J Ophthalmol; 2021 May; 105(5):723-728. PubMed ID: 32606081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients Perceptions of Artificial Intelligence in Diabetic Eye Screening.
    Yap A; Wilkinson B; Chen E; Han L; Vaghefi E; Galloway C; Squirrell D
    Asia Pac J Ophthalmol (Phila); 2022 May; 11(3):287-293. PubMed ID: 35772087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are the perceptions and concerns of people living with diabetes and National Health Service staff around the potential implementation of AI-assisted screening for diabetic eye disease? Development and validation of a survey for use in a secondary care screening setting.
    Willis K; Chaudhry UAR; Chandrasekaran L; Wahlich C; Olvera-Barrios A; Chambers R; Bolter L; Anderson J; Barman SA; Fajtl J; Welikala R; Egan C; Tufail A; Owen CG; Rudnicka A; ;
    BMJ Open; 2023 Nov; 13(11):e075558. PubMed ID: 37968006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application.
    Bellemo V; Lim G; Rim TH; Tan GSW; Cheung CY; Sadda S; He MG; Tufail A; Lee ML; Hsu W; Ting DSW
    Curr Diab Rep; 2019 Jul; 19(9):72. PubMed ID: 31367962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.
    Wolf RM; Channa R; Abramoff MD; Lehmann HP
    JAMA Ophthalmol; 2020 Oct; 138(10):1063-1069. PubMed ID: 32880616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Intelligence Algorithms in Diabetic Retinopathy Screening.
    Zafar S; Mahjoub H; Mehta N; Domalpally A; Channa R
    Curr Diab Rep; 2022 Jun; 22(6):267-274. PubMed ID: 35438458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of deep learning-based artificial intelligence models in screening and referring patients with diabetic retinopathy and glaucoma.
    Surya J; Garima ; Pandy N; Hyungtaek Rim T; Lee G; Priya MNS; Subramanian B; Raman R
    Indian J Ophthalmol; 2023 Aug; 71(8):3039-3045. PubMed ID: 37530278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Deep Convolutional Neural Network-based algorithm for detection of diabetic retinopathy - Artificial intelligence versus clinician for screening.
    Shah P; Mishra DK; Shanmugam MP; Doshi B; Jayaraj H; Ramanjulu R
    Indian J Ophthalmol; 2020 Feb; 68(2):398-405. PubMed ID: 31957737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a novel artificial intelligence-based screening system for diabetic retinopathy in community of China: a real-world study.
    Ming S; Xie K; Lei X; Yang Y; Zhao Z; Li S; Jin X; Lei B
    Int Ophthalmol; 2021 Apr; 41(4):1291-1299. PubMed ID: 33389425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Economic and Safety Considerations for Artificial Intelligence Applications in Diabetic Retinopathy Screening.
    Xie Y; Gunasekeran DV; Balaskas K; Keane PA; Sim DA; Bachmann LM; Macrae C; Ting DSW
    Transl Vis Sci Technol; 2020 Apr; 9(2):22. PubMed ID: 32818083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
    Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
    JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Intelligence in the assessment of diabetic retinopathy from fundus photographs.
    Gilbert MJ; Sun JK
    Semin Ophthalmol; 2020 Nov; 35(7-8):325-332. PubMed ID: 33539253
    [No Abstract]   [Full Text] [Related]  

  • 16. ARTEFICIAL INTELLIGENCE IN DIABETIC RETINOPATHY SCREENING. A REVIEW.
    Straňák Z; Penčák M; Veith M
    Cesk Slov Oftalmol; 2021; 77(5):224-231. PubMed ID: 34666491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge, attitude and practices on diabetes, hypertension and diabetic retinopathy and the factors that motivate screening for diabetes and diabetic retinopathy in a pyramidal model of eye health care.
    Lingam S; Rani PK; Sheeladevi S; Kotapati V; Das T
    Rural Remote Health; 2018 Feb; 18(1):4304. PubMed ID: 29458256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's attitudes and perspectives on the use of artificial intelligence in the assessment of screening mammograms.
    Holen ÅS; Martiniussen MA; Bergan MB; Moshina N; Hovda T; Hofvind S
    Eur J Radiol; 2024 Jun; 175():111431. PubMed ID: 38520804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Can Artificial Intelligence Be Implemented Effectively in Diabetic Retinopathy Screening in Japan?
    Kawasaki R
    Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using artificial intelligence for diabetic retinopathy screening: Policy implications.
    Raman R; Dasgupta D; Ramasamy K; George R; Mohan V; Ting D
    Indian J Ophthalmol; 2021 Nov; 69(11):2993-2998. PubMed ID: 34708734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.